Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen Receptor-positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00952731
What this trial is testing

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

Who this might be right for
Ductal Breast Carcinoma in SituEstrogen Receptor-positive Breast Cancer
Northwestern University 27
Large-scale testing (Phase 3)Ended earlyNCT00267553
What this trial is testing

Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasms, Hormone-Dependent
Intarcia Therapeutics 200
Not applicableStudy completedNCT00755313
What this trial is testing

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityCognitive/Functional Effects+4 more
University of California, San Francisco 81
Testing effectiveness (Phase 2)Study completedNCT02811497
What this trial is testing

Study of Azacitidine and Durvalumab in Advanced Solid Tumors

Who this might be right for
Microsatellite Stable Colorectal CarcinomaPlatinum Resistant Epithelial Ovarian Cancer Type IIEstrogen Receptor Positive and HER2 Negative Breast Cancer
University Health Network, Toronto 28
Early research (Phase 1)Study completedNCT04514159
What this trial is testing

ZN-c5 and Abemaciclib in Participants With Breast Cancer

Who this might be right for
Breast Cancer
Zeno Alpha Inc. 14
Very early researchWithdrawnNCT04630210
What this trial is testing

Investigating Atezolizumab in Newly Diagnosed ER Positive Breast Cancer Patients According to Their AdipOsity

Who this might be right for
Breast Cancer
Universitaire Ziekenhuizen KU Leuven
Large-scale testing (Phase 3)UnknownNCT04046159
What this trial is testing

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

Who this might be right for
Breast Ductal Carcinoma in Situ
National Taiwan University Hospital 810
Not applicableStudy completedNCT03285568
What this trial is testing

Patterns of Prescribing and Monitoring of Palbociclib

Who this might be right for
Metastatic Breast CancerAdvanced Breast CancerEstrogen Receptor-positive Breast Cancer+1 more
Rush University Medical Center 67
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07173556
What this trial is testing

A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Qilu Pharmaceutical Co., Ltd. 96
Testing effectiveness (Phase 2)Study completedNCT05896566
What this trial is testing

A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 231
Large-scale testing (Phase 3)Study completedNCT01564056
What this trial is testing

Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment

Who this might be right for
Breast Cancer
UNICANCER 1,989
Not applicableUnknownNCT04101656
What this trial is testing

Accelerated Partial Irradiation of the Breast: New Altered Fractionation

Who this might be right for
Breast Cancer
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 174
Testing effectiveness (Phase 2)Study completedNCT02668666
What this trial is testing

Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Hormone Receptor Positive Malignant Neoplasm of BreastHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastEstrogen Receptor Positive Breast Cancer+2 more
Oana Danciu, MD 49
Testing effectiveness (Phase 2)Study completedNCT00828854
What this trial is testing

Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing

Who this might be right for
ER+ Breast Cancer
Syndax Pharmaceuticals 27
Testing effectiveness (Phase 2)Looking for participantsNCT06028022
What this trial is testing

Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors

Who this might be right for
Estrogen Receptor-Positive Breast Carcinoma
Mayo Clinic 80
Large-scale testing (Phase 3)WithdrawnNCT00053339
What this trial is testing

Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer

Who this might be right for
Stage IV Breast CancerRecurrent Breast Cancer
Alliance for Clinical Trials in Oncology
Early research (Phase 1)Study completedNCT02599714
What this trial is testing

Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer

Who this might be right for
Advanced and Metastatic Breast Cancer
AstraZeneca 54
Testing effectiveness (Phase 2)Looking for participantsNCT07287098
What this trial is testing

Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Who this might be right for
Breast Neoplasms
Eli Lilly and Company 600
Large-scale testing (Phase 3)Study completedNCT00949598
What this trial is testing

Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer

Who this might be right for
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 177
Early research (Phase 1)Study completedNCT02900664
What this trial is testing

PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Who this might be right for
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
Novartis Pharmaceuticals 283
Next Page